written by Michael O’Leary
People with type 2 diabetes may find that a new GLP-1 drug being tested in clinical trials may help to control both their blood sugar and their high blood pressure.
A large study was presented last week at the 27th American Society of Hypertension Scientific Meeting by Tulane University School of Medicine researchers. Led by Dr. Keith C. Ferdinand, the researchers found that the drug, dulaglutide being developed by Eli Lilly, lowered blood pressure by a significant amount compared to a placebo. (Published site)
People with type 2 diabetes may find that a new GLP-1 drug being tested in clinical trials may help to control both their blood sugar and their high blood pressure.
A large study was presented last week at the 27th American Society of Hypertension Scientific Meeting by Tulane University School of Medicine researchers. Led by Dr. Keith C. Ferdinand, the researchers found that the drug, dulaglutide being developed by Eli Lilly, lowered blood pressure by a significant amount compared to a placebo. (Published site)